Exact Mass: 451.1757

Exact Mass Matches: 451.1757

Found 152 metabolites which its exact mass value is equals to given mass value 451.1757, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Doxazosin

1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine

C23H25N5O5 (451.1856)


Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors. It may be used to mild to moderate hypertension and in the management of symptomatic benign prostatic hyperplasia (BPH). α1-Receptors mediate contraction and hypertrophic growth of smooth muscle cells. Antagonism of these receptors leads to smooth muscle relaxation in the peripheral vasculature and prostate gland. C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide

4-Amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-hydroxybenzene-1-carboximidate

C22H27ClFN3O4 (451.1674)


   

4-Hydroxypropranolol glucuronide

3,4,5-trihydroxy-6-[(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}naphthalen-1-yl)oxy]oxane-2-carboxylic acid

C22H29NO9 (451.1842)


   

Succinyl-trialanine-4-nitroanilide

3-[(1-{[1-({1-[(4-nitrophenyl)carbamoyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]propanoate

C19H25N5O8 (451.1703)


   

(2S)-2-((3-((4-(4-Fluorophenoxy)phenyl)methylcarbamoyl)-4-methoxy-phenyl)methyl)butanoic acid

2-{[3-({[4-(4-fluorophenoxy)phenyl]methyl}-C-hydroxycarbonimidoyl)-4-methoxyphenyl]methyl}butanoate

C26H26FNO5 (451.1795)


   

Pseudolycorine-1-O-beta-D-glucoside

Pseudolycorine-1-O-beta-D-glucoside

C22H29NO9 (451.1842)


   
   

(1S,4R)-1-(beta-D-Glucopyranosyloxy)-4-(6-deoxy-beta-D-gulopyranosyloxy)-2-cyclopentene-1-carboxamide

(1S,4R)-1-(beta-D-Glucopyranosyloxy)-4-(6-deoxy-beta-D-gulopyranosyloxy)-2-cyclopentene-1-carboxamide

C18H29NO12 (451.169)


   

doxazosin

Doxazosin, (R)-

C23H25N5O5 (451.1856)


C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3293

   

Ala Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1672)


   

Ala Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Ala Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Ala Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Ala Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Cys Ala Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Cys Arg Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]propanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Asp Lys Ser

(3S)-3-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pentyl]carbamoyl}-3-[(2R)-2-amino-3-sulfanylpropanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Cys Asp Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-hydroxypropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Cys Lys Asp Ser

(3S)-3-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Cys Lys Ser Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Cys Gln Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Cys Arg Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Arg Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N7O5S2 (451.1672)


   

Cys Arg Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

Cys Ser Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carboxypropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Cys Ser Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Cys Ser Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

Cys Ser Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O7S (451.1849)


   

Cys Thr Gln Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Cys Thr Thr Gln

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Asp Cys Lys Ser

(3S)-3-amino-3-{[(1R)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pentyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Asp Cys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Asp Phe Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]acetamido}-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Asp Phe Asn Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Asp Gly Phe Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-phenylpropanamido]-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Asp Gly Asn Phe

(3S)-3-amino-3-[({[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H25N5O8 (451.1703)


   

Asp Lys Cys Ser

(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}pentyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Asp Lys Ser Cys

(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}pentyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Asp Asn Phe Gly

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Asp Asn Gly Phe

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Asp Ser Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Asp Ser Lys Cys

(3S)-3-amino-3-{[(1S)-1-{[(1S)-5-amino-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pentyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Phe Asp Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]acetamido}-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Phe Asp Asn Gly

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Phe Gly Asp Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-carboxypropanamido]-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Phe Gly Asn Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-carbamoylpropanamido]butanedioic acid

C19H25N5O8 (451.1703)


   

Phe Asn Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H25N5O8 (451.1703)


   

Phe Asn Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]acetamido}butanedioic acid

C19H25N5O8 (451.1703)


   

Gly Asp Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Gly Asp Asn Phe

(3S)-3-(2-aminoacetamido)-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Gly Phe Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C19H25N5O8 (451.1703)


   

Gly Phe Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C19H25N5O8 (451.1703)


   

Gly Asn Asp Phe

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Gly Asn Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-phenylpropanamido]butanedioic acid

C19H25N5O8 (451.1703)


   

Lys Cys Asp Ser

(3S)-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Lys Cys Ser Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Lys Asp Cys Ser

(3S)-3-{[(1R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-3-[(2S)-2,6-diaminohexanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Lys Asp Ser Cys

(3S)-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-3-[(2S)-2,6-diaminohexanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Lys Ser Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Lys Ser Asp Cys

(3S)-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Met Asn Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Met Asn Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Met Gln Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Met Ser Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Met Ser Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Met Ser Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Met Ser Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Met Thr Asn Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Met Thr Ser Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Asn Asp Phe Gly

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Asn Asp Gly Phe

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H25N5O8 (451.1703)


   

Asn Phe Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H25N5O8 (451.1703)


   

Asn Phe Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]acetamido}butanedioic acid

C19H25N5O8 (451.1703)


   

Asn Gly Asp Phe

(3S)-3-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C19H25N5O8 (451.1703)


   

Asn Gly Phe Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-phenylpropanamido]butanedioic acid

C19H25N5O8 (451.1703)


   

Asn Met Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Asn Met Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Asn Ser Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Asn Ser Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Asn Thr Met Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Asn Thr Ser Met

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Gln Cys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Gln Met Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Gln Ser Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Gln Ser Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Gln Thr Cys Thr

(2S,3R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Gln Thr Thr Cys

(2R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H29N5O8S (451.1737)


   

Arg Ala Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Arg Cys Ala Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N7O5S2 (451.1672)


   

Arg Cys Cys Ala

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N7O5S2 (451.1672)


   

Arg Cys Ser Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

4-Hydroxypropranolol glucuronide

4-Hydroxypropranolol glucuronide

C22H29NO9 (451.1842)


   

Arg Ser Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

Arg Ser Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N7O7S (451.1849)


   

Ser Cys Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Ser Cys Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Ser Cys Arg Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

Ser Cys Ser Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O7S (451.1849)


   

Ser Asp Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]hexanoic acid

C16H29N5O8S (451.1737)


   

Ser Asp Lys Cys

(3S)-3-{[(1S)-5-amino-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pentyl]carbamoyl}-3-[(2S)-2-amino-3-hydroxypropanamido]propanoic acid

C16H29N5O8S (451.1737)


   

Ser Lys Cys Asp

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanamido]butanedioic acid

C16H29N5O8S (451.1737)


   

Ser Lys Asp Cys

(3S)-3-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C16H29N5O8S (451.1737)


   

Ser Met Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Ser Met Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Ser Met Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Ser Met Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Ser Asn Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Ser Asn Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Ser Gln Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Ser Gln Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Ser Arg Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N7O7S (451.1849)


   

Ser Arg Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N7O7S (451.1849)


   

Ser Ser Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C15H29N7O7S (451.1849)


   

Ser Ser Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Ser Ser Gln Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Ser Ser Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C15H29N7O7S (451.1849)


   

Ser Thr Met Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Ser Thr Asn Met

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Thr Cys Gln Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Thr Cys Thr Gln

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Thr Met Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Thr Met Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Thr Asn Met Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid

C16H29N5O8S (451.1737)


   

Thr Asn Ser Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Thr Gln Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H29N5O8S (451.1737)


   

Thr Gln Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H29N5O8S (451.1737)


   

Thr Ser Met Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C16H29N5O8S (451.1737)


   

Thr Ser Asn Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H29N5O8S (451.1737)


   

Thr Thr Cys Gln

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H29N5O8S (451.1737)


   

Thr Thr Gln Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C16H29N5O8S (451.1737)


   

Nap-Lys-OH

(S)-7-amino-2-(3-(naphthalen-2-ylmethoxy)-4-nitrobenzamido)heptanoic acid

C24H25N3O6 (451.1743)


   

Lys-Nap-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-(naphthalen-2-yl)butanoic acid

C24H25N3O6 (451.1743)


   

Lavofloxacin Lactate

Lavofloxacin Lactate

C21H26FN3O7 (451.1755)


   

Fmoc-(R)-3-Amino-4-(1-naphthyl)-butyric acid

Fmoc-(R)-3-Amino-4-(1-naphthyl)-butyric acid

C29H25NO4 (451.1783)


   

4-methylumbelliferyl a-l-idopyranosiduronic acid, cyclohexylammonium salt

4-methylumbelliferyl a-l-idopyranosiduronic acid, cyclohexylammonium salt

C22H29NO9 (451.1842)


   

fmoc-(s)-3-amino-4-(2-naphthyl)-butyric acid

fmoc-(s)-3-amino-4-(2-naphthyl)-butyric acid

C29H25NO4 (451.1783)


   

Suc-Ala-Ala-Ala-pNA

Suc-Ala-Ala-Ala-pNA

C19H25N5O8 (451.1703)


   

poldine metilsulfate

poldine metilsulfate

C22H29NO7S (451.1665)


   

Fmoc-(S)-3-Amino-4-(1-naphthyl)-butyric acid

Fmoc-(S)-3-Amino-4-(1-naphthyl)-butyric acid

C29H25NO4 (451.1783)


   

Fmoc-(R)-3-Amino-4-(2-naphthyl)-butyric acid

Fmoc-(R)-3-Amino-4-(2-naphthyl)-butyric acid

C29H25NO4 (451.1783)


   

Dihydrocodeine bitartrate

Dihydrocodeine bitartrate

C22H29NO9 (451.1842)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-4-(2H-tetrazol-5-YL)-butyric acid

2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-4-(2H-tetrazol-5-YL)-butyric acid

C20H21N9O4 (451.1716)


   

4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide

4-Amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-hydroxybenzene-1-carboximidate

C22H27ClFN3O4 (451.1674)


   

(2S)-2-((3-((4-(4-Fluorophenoxy)phenyl)methylcarbamoyl)-4-methoxy-phenyl)methyl)butanoic acid

2-{[3-({[4-(4-fluorophenoxy)phenyl]methyl}-C-hydroxycarbonimidoyl)-4-methoxyphenyl]methyl}butanoate

C26H26FNO5 (451.1795)


   

Suc-DL-Ala-DL-Ala-DL-Ala-pNA

Suc-DL-Ala-DL-Ala-DL-Ala-pNA

C19H25N5O8 (451.1703)


   

7-{2-Hydroxy-3-[(naphthalen-1-yl)oxy]propyl}-3-methyl-8-(morpholin-4-yl)-3,7-dihydropurine-2,6-dione

7-{2-Hydroxy-3-[(naphthalen-1-yl)oxy]propyl}-3-methyl-8-(morpholin-4-yl)-3,7-dihydropurine-2,6-dione

C23H25N5O5 (451.1856)


   

ST 20:4;O7;Gly

ST 20:4;O7;Gly

C22H29NO9 (451.1842)


   
   

PRGL493

PRGL493

C25H21N7O2 (451.1757)


PRGL493 is a potent and selective long-chain acyl-CoA synthetase 4 (ACSL4) inhibitor. PRGL493 blocks cell proliferation and tumor growth in both breast and prostate cellular and animal models. PRGL493 is used for cancer research[1].

   

(2r,3s,4s,5r,6s)-2-{[(1r,14s,15s,16s)-4,14-dihydroxy-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-{[(1r,14s,15s,16s)-4,14-dihydroxy-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C22H29NO9 (451.1842)


   

(4s)-4-({1-methoxy-4-methyl-3-oxobenzo[f]1,7-naphthyridin-5-yl}formamido)-7-methyl-5-oxooct-6-enoic acid

(4s)-4-({1-methoxy-4-methyl-3-oxobenzo[f]1,7-naphthyridin-5-yl}formamido)-7-methyl-5-oxooct-6-enoic acid

C24H25N3O6 (451.1743)


   

1,2,2-tris[(2-hydroxyphenyl)methyl]indol-3-one

1,2,2-tris[(2-hydroxyphenyl)methyl]indol-3-one

C29H25NO4 (451.1783)